HPV Vaccination Programs:

From Pre-introduction Planning to Restoration and Sustainability

September 2022 – Addis Ababa, Ethiopia

 

Meeting Objectives

One of the main objectives of the symposium is to create an HPV community in the global south by engaging countries at different levels of HPV vaccination program introduction to:

 

  • Share experiences and lessons learned
  • Discuss evidence-based policies and program implementation in and across countries
  • Contribute to  the research agenda to accelerate progress in HPV vaccine introduction, access, program optimization, restoration, and sustainability
  • Discuss new developments in the field and health models that can be integrated with HPV vaccination programs
  • Provide updated information on available data on HPV vaccine evaluation including schedules
  • Discuss integration of HPV vaccination programs with adolescent health services.

Saturday, 24th September 2022

SESSION 1: INAUGURAL SESSION (Video ENG, Video FR)
  • Welcome Note
    Honorable State Minister of Health Ethiopia
    HE Dr Dereje Duguma
  • Welcome & Introduction
    CHIC SPC Secretariat
    Dr. Alex Vorsters, Dr. Nelly Mugo, Dr. Margaret Stanley (online)
  • Co-host- FMOH Ethiopia
    Dr. Meseret Zelalem, Mr. Yohannes Lakew, Mr. Mengistu Bogale
  • Co-host – Ethiopia Society of Gynaecology and Obstetrics (ESOG)
    Dr. Abdulfetah Abdulkadir (President ESOG)
  • Participants Introduction

    SESSION 2: CERVICAL CANCER PREVENTION LANDSCAPE
    Chairs: Dr. Velepi Mtonga & Dr. Mario Poljak

    • HPV related cancers incidence, mortality, social and economic impact in Africa
      Ms. Ann Korir (KEMRI, ACRN)
      (Pdf, Video ENG, Video FR)
    • HPV vaccination programs – regional overview
      Dr. Phionah Atuhebwe (WHO)
      (Pdf, Video ENG, Video FR)
    • Q&A

    SESSION 3: ENSURING EFFECTIVE INTRODUCTIONS: EXPERIENCES AND LESSONS LEARNED FROM DECISION-MAKING, PLANNING, AND PREPARATION OF HPV VACCINATION PROGRAMS
    SESSION 3A: LOCAL DATA AVAILABILITY: DENOMINATOR DATA, DATA FOR PLANNING AND STRENGTHENING HEALTH INFORMATION SYSTEMS
    Chairs:  Dr. Portia Manangazira (Director of Epidemiology and Disease Control at Ministry of Health & Child Care, Zimbabwe) & Dr. Driwale Alfred (Assistant Commissioner of Health Services: Vaccines & Immunization, Uganda)

    Local data availability: denominator data, data for planning and strengthening health information systems

    • Ethiopia Immunization Monitoring System
      Mr. Yohannes Lakew (EPI, MOH Ethiopia)
      (Pdf, Video ENG, Video FR)
    • Rwanda data availability: Denominator data, data for planning and strengthening health information systems
      Ms. Irene Mukanyandwi  (EPI, MOH Rwanda) – Online
      (Pdf, Video ENG, Video FR)
    • Q&A
    • Tracking, and follow-up – Lessons learned from other vaccination programs
      Mr. Kebba Touray & Ms. Marie Babona Nshuti (WHO)
      (Pdf, Video ENG, Video FR)
    • Local solutions for data generation, collection, and reporting/ improving health information systems for HPV vaccines
      Q&A & Discussion

    SESSION 3B: EXPERIENCES AND LESSONS LEARNED FROM DECISION-MAKING, PLANNING, AND PREPARATION OF HPV VACCINATION PROGRAMS
    Chairs: Messeret Shibeshi (WHO) & Dr. Furaha Kyesi ( EPI, MOH, Tanzania)

    • Timely preparedness assessment, associated challenges, and impact on planning
      Ms. Temwa Stella Mzengeza (Malawi Ministry of Health)
      (Pdf, Video ENG, Video FR)​
    • Importance of stakeholder inclusion and coordination in the planning and introduction of the HPV vaccination program in Côte d’Ivoire / Importance de l’inclusion et de la coordination des parties prenantes dans la planification et l’introduction du programme de vaccination contre le HPV en Côte d’Ivoire
      Dr. Innocent Massenon (Chargé de prestation à la Direction de Coordination du Programme Elargi de Vaccination)
      (Pdf, Video ENG, Video FR)
    • Q&A

    SESSION 3C: GAVI APPLICATION PROCESS: PROCESS, BOTTLE NECKS AND LESSONS LEARNED
    Chairs: Dr. Landry Kaucley (EPI Manager, Benin) & Dr. Kwame Amponsa Achiano (EPI Manager, Ghana)

    GAVI application process, challenges and lessons learned

    • Mozambique’s Experience with the Introduction of the HPV Vaccine
      Ms. Amelia Dipuve (EPI, MOH Mozambique)
      (Pdf, Video ENG)
    • GAVI application process, challenges and lessons learned
      Dr. Landry Kaucley (EPI Manager, Benin)
      (Pdf, Video ENG, Video FR)
    • Q&A

    SESSION 3D: PANEL DISCUSSION ON TIMELY PLANNING AND THE IMPORTANCE OF IMPROVING PARTNERSHIPS
    Chairs: Rose Dlamini ( WHO WR Ethiopia) & Ms. Sarah Wanyoike (Jhpiego)

    • HPV Vaccination Program Introduction Challenges; An overview from National Stakeholders
      Dur-e-Nayab Waheed (University of Antwerp) & Dominique Guillaume (John Hopkins University School of Nursing, Jhpiego)
      (Pdf, Video ENG, Video FR)
    • Planning framework, human resource, and stakeholders’ inclusion/ Timely planning and improving partnerships
      Panelists: Dr. Furaha Kyesi (EPI, MOH, Tanzania),  Colline Chigodo (EPI Zimbabwe), Dr. Francis Dien Mwansa (MOH  Zambia)  Lucy Kiari (JSI), Dr. Driwale Alfred (EPI, Uganda), Ms Temwa Mzengeza (EPI, Malawi), Chris Morgan (Jhpiego)
      (Video ENG)

    SESSION 4A: PROGRAMMATIC CONSIDERATION – DOSING SCHEDULES: GUIDELINES, NEW STRATEGIES, AND FUTURE APPROACHES
    Chairs: Dr. Nelly Mugo (KEMRI, Kenya) & Prof. Margaret Stanley (University of Cambridge, UK)

    • Efficacy of single-dose HPV vaccination among young African women (KEN SHE)
      Dr. Maricianah Onono (Kenya)
      (Pdf, Video ENG, Video FR)
    • One dose trial data
      Dr. Deborah Watson-Jones (Tanzania) – Online
      (Pdf, Video ENG, Video FR)
    • Q&A
    • One dose: current guidelines, available vaccines and opportunities for MAC catchup programs with one dose
      Dr. Hiroki Akaba (WHO)
      (Pdf, Video ENG, Video FR)
    • One dose decision making in Nigeria
      A progress toward successful HPV Introduction and accelerating coverage in Nigeria
      Dr. Garba Bakunawa (NHPCDA, Nigeria)
      (Pdf, Video ENG, Video FR)
    • Q&A

    SESSION 4B: PROGRAMMATIC CONSIDERATIONS: DELIVERY PLATFORMS AND NEW STRATEGIES, AND FUTURE APPROACHES
    Chairs Dr. Anissa Sidibe (GAVI) – Online & Dr. Deborah Watson Jones (Tanzania)

    HPV Vaccine Delivery:  What are current delivery strategies? How are countries restoring coverage following Covid-19 interruptions

    • The Gambia HPV Vaccine Delivery; current delivery strategy and plans for restoring coverage following Covid-19 interruption
      Ms. Mamanding Kinteh (EPI Focal person, The Gambia)
      (Pdf, Video ENG, Video FR)Mr. Eric Chisupa (EPI Zambia)
      (Pdf, Video ENG, Video FR)
    • HPV Vaccine delivery strategies Kenya
      Ms. Christine Miano  (EPI, Kenya)
      (Pdf, Video ENG, Video FR)
    • HPV Vaccine Delivery – Liberia
      Dr. Adolphus Clark (EPI Manager, Liberia)
      (Pdf)
    • Discussion on delivery strategies: Are school based programs sustainable? How HPV vaccine delivery platforms can be made sustainable?
      (Video ENG, Video FR)
    • Introduction during Covid-19: implications and strategies to tackle interruptions. The case of Cameroon
      Dr. Andreas Njoh Ateke (EPI, Cameroon)
      (Pdf, Video ENG, Video FR)
    • Q&A

    Sunday, 25 September 2022

    DAY 2: INTRODUCTION

    SESSION 5: ADVOCACY, COMMUNICATION, AND SOCIAL MOBILIZATION AMONG HEALTH WORKFORCE FOR HPV VACCINATION
    Chairs: Sabrina Kitaka (Makerere University, Uganda) & Zoey Diaz (BMGF)

    • HPV communication plan: crisis management plan, needs and lessons learnt/ Plan de communication HPV: Gestion des crises et leçons apprises (Le cas du Sénégal)
      Mrs. Raabi Diouf (UNICEF, Senegal)
      (Pdf, Video ENG, Video FR)

    Communication for health work force at the district level: approaches and challenges

    • HPV Communication for healthcare workers at facility level: Approaches and challenges
      Rosemary Njura Njogu (Jhpiego, Kenya)
      (Pdf, Video ENG, Video FR)
    • Social Mobilization and advocacy in Sebeta, Ethiopia
      Mrs. Belaynesh Mekonnen (Healthcare professional, Ethiopia)
      (Pdf, Video ENG, Video FR)
    • Discussion

    SESSION 6A: TRAINING AND SENSITIZATION OF STAKEHOLDERS INVOLVED IN DECISION-MAKING, PLANNING AND IMPLEMENTATION
    Chairs: Dr. Mutale Mumba (WHO) & Mengistu Bogale (EPI, MOH Ethiopia)

    • Training and Sensitization: A critical aspect of a vaccination program and implication on HPV vaccination programs
      Mengistu Bogale (EPI, MOH Ethiopia)
      (Pdf, Video ENG, Video FR)​
    • Discussion

    SESSION 6B: TRAINING OF HEALTH WORKFORCE (VACCINATORS/HEALTHCARE PROFESSIONALS/ FRONT LINE WORKERS
    Chairs: Dr. Mutale Mumba (WHO) & Dur-e-Nayab Waheed (University of Antwerp)

    • Training of healthcare professionals(HCP) at the district level; challenges and gaps
      Thomas Lweya  (EPI coordinator for Ntchisi district, Malawi)
      (Pdf, Video ENG, Video FR)
    • Optimizing training approaches: considerations for program implementers
      Joseph Rujumba (Makerere University, Uganda)
      (Pdf, Video ENG, Video FR)
    • Discussion

    SESSION 7: SUSTAINABILITY AND RESTORING HPV VACCINATION PROGRAMS
    Chairs: Cathy Ndiaye (PATH) & Christopher Morgan (Jhpiego)

    HPV vaccine delivery strategy, how to move towards sustainable delivery platforms and the facilitators to achieve sustainable coverage

    • HPV vaccine delivery strategy in Tanzania – Towards sustainable delivery platforms and coverage
      Dr. Florian Tinuga ( EPI, MOH, Tanzania)
      (Pdf, Video ENG, Video FR)Dr. Meseret Zelalem (MCHND Director, Federal Ministry of Health Ethiopia)
      (Pdf, Video ENG, Video FR)
    • Intensifying immunization of girls aged 9-14 years as a mitigation strategy for COVID- 19 on HPV Vaccination: Experience in Côte d’Ivoire/ Intensification de la vaccination des filles de 9-14 ans comme stratégie d’atténuation des effets de la COVID-19sur la vaccination contre le HPV : Expérience de la Côte d’Ivoire
      Kouakou Seraphin (Jhpiego, Cote d’Ivoire)
      (Pdf, Video ENG, Video FR)
    • Q&A
    • Opportunities for integrating HPV vaccination program with adolescent health services
      Clarence Mbanga (CHAI, Cameroon)
      (Pdf, Video ENG, Video FR)
    • Q&A

    SESSION 8: CERVICAL CANCER ELIMINATION PARTNERS LANDSCAPE AND THEIR ACTIVITIES
    Chairs: Dr. Vellepi Mtonga & Dr. Yirgu Gebrehiwot

    SESSION 9: BREAKOUT GROUPS
    Chairs: University of Antwerp Team

    • Breakout group 1: Professional associations and their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
      Chairs:
    • Breakout group 2: NGOs and Implementers and their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
      Chairs:
    • Breakout group 3: MOH & Global partners  –  their role in planning, implementation and scale-up of HPV vaccination programs, the existing challenges and the way forward
      Chairs:
    • Plenary feedback per group in the main session (Video ENG, Video FR)

    ​SESSION 10: CONCLUSIONS
    Chairs: Prof. Dr. Mathuram Santosham (John Hopkins University) & Prof. Dr. Alex Vorsters (University of Antwerp)